Table 3. Logistic regression analyses for recurrence by miRNA expression in tissues.
| Univariate | Multivariate | |||
|---|---|---|---|---|
| miRNA (high vs. low) | OR (95% CI) | P | ORa (95% CI) | P |
| has-miR-338-3p | 1.97 (0.72–5.42) | 0.189 | ||
| has-miR-340-5p | 4.13 (1.38–12.4) | 0.011 | 2.58 (0.69–9.66) | 0.159 |
| has-miR-124-3p | 0.88 (0.31–2.47) | 0.810 | ||
| has-miR-29b-3p | 1.78 (0.62–5.10) | 0.286 | ||
| has-miR-20b-5p | 2.70 (0.93–7.85) | 0.068 | ||
| has-miR-17-5p | 3.25 (1.07–9.84) | 0.037 | 1.61 (0.41–6.36) | 0.500 |
| has-miR-130a-3p | 3.25 (1.07–9.84) | 0.037 | 1.76 (0.46–6.69) | 0.409 |
| has-miR-18a-5p | 1.69 (0.65–4.38) | 0.282 | ||
| has-miR-195-5p | 2.70 (0.93–7.85) | 0.068 | ||
| has-miR-486-5p | 1.16 (0.42–3.24) | 0.777 | ||
| has-miR-93-5p | 6.56 (1.91–22.5) | 0.003 | 5.58 (1.46–21.3) | 0.012 |
OR, odds ratio; CI, confidence interval.
aOR was adjusted for tumor size, miR-340-5p, miR-17-5p, miR-130a-3p, and miR-93-5p.